Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MEDIQ A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.2% 1.2%   Bankruptcy risk   2.3% 3.3% 2.6% 3.1% 2.5% 3.2% 11.0% 11.0%   Credit score (0-100)   67 56 61 55 62 55 22 22   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,294 1,999 1,415 1,196 1,384 1,837 0.0 0.0   EBITDA   1,412 1,119 554 352 531 993 0.0 0.0   EBIT   1,412 1,119 554 352 531 993 0.0 0.0   Pre-tax profit (PTP)   1,372.0 1,100.1 536.5 342.2 528.7 993.8 0.0 0.0   Net earnings   1,069.1 856.9 418.3 266.8 411.6 775.1 0.0 0.0   Pre-tax profit without non-rec. items   1,372 1,100 536 342 529 994 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   2,405 2,962 1,381 1,047 1,459 2,234 934 934   Interest-bearing liabilities   1,125 842 393 124 74.1 57.7 0.0 0.0   Balance sheet total (assets)   4,371 4,348 2,399 1,552 2,002 3,957 934 934   Net Debt   -1,793 -3,082 -1,297 -567 -1,124 -3,459 -934 -934     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,294 1,999 1,415 1,196 1,384 1,837 0.0 0.0   Gross profit growth   40.0% -12.9% -29.2% -15.5% 15.7% 32.7% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,371 4,348 2,399 1,552 2,002 3,957 934 934   Balance sheet change%   39.7% -0.5% -44.8% -35.3% 29.1% 97.6% -76.4% 0.0%   Added value   1,411.8 1,119.4 554.0 351.6 530.9 992.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   61.5% 56.0% 39.1% 29.4% 38.4% 54.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   37.6% 25.7% 16.4% 17.8% 30.0% 33.4% 0.0% 0.0%   ROI %   47.9% 30.5% 19.9% 23.9% 39.5% 52.0% 0.0% 0.0%   ROE %   52.9% 31.9% 19.3% 22.0% 32.8% 42.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   56.1% 68.1% 57.6% 67.5% 72.9% 72.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -127.0% -275.3% -234.1% -161.2% -211.7% -348.4% 0.0% 0.0%   Gearing %   46.8% 28.4% 28.4% 11.8% 5.1% 2.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.3% 2.0% 2.8% 3.6% 5.3% 2.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.3 3.1 2.4 3.1 3.7 4.7 0.0 0.0   Current Ratio   2.2 3.1 2.4 3.1 3.7 2.3 0.0 0.0   Cash and cash equivalent   2,918.2 3,924.0 1,689.8 690.5 1,197.9 3,516.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   2,405.3 2,962.2 1,380.6 1,047.4 1,459.0 2,234.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   1,412 1,119 554 352 531 993 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   1,412 1,119 554 352 531 993 0 0   EBIT / employee   1,412 1,119 554 352 531 993 0 0   Net earnings / employee   1,069 857 418 267 412 775 0 0